An Act protecting patient safety regarding non-FDA approved drugs
Accompanied a study order, see H5234
Summary
The bill forbids any retail pharmacy in Massachusetts from selling compounded medications to anyone other than the patient for whom they were prepared. It also requires detailed labeling on compounded drugs and gives the state pharmacy board authority to fine, suspend, or revoke licenses for violations. The goal is to protect patient safety by ensuring compounded drugs are used only as intended.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when H 2472 changes status, plus AI-powered summaries and stage predictions.
Sign up free